0.6703
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt SCYX?
Forum
Prognose
Aktiensplit
Scynexis Inc Aktie (SCYX) Neueste Nachrichten
12 Health Care Stocks Moving In Thursday's After-Market Session - Benzinga
Will SCYNEXIS Inc. (135A) stock outperform foreign stocksJuly 2025 Action & Risk Managed Trade Strategies - newser.com
Is SCYNEXIS Inc. (135A) stock considered safe havenGap Up & Smart Allocation Stock Tips - newser.com
Analyzing recovery setups for SCYNEXIS Inc. investorsFed Meeting & Fast Gain Stock Trading Tips - newser.com
Will SCYNEXIS Inc. stock recover faster than peersJuly 2025 Update & Technical Pattern Alert System - newser.com
Scynexis Transfers Brexafemme New Drug Application to GSK - MarketScreener
SCYNEXIS, Inc. Completes Transfer of Brexafungerp New Drug Application to Gsk - MarketScreener
Scynexis completes transfer of Brexafemme new drug application to GSK - MarketScreener
SCYNEXIS Completes BREXAFEMME NDA Transfer to GSK, Positioning for Future Milestones and Royalties - Quiver Quantitative
SCYNEXIS Completes Transfer of BREXAFEMME® New Drug Application to GSK - The Manila Times
Scynexis completes transfer of Brexafemme New Drug Application To GSK - TradingView
SCYNEXIS (NASDAQ: SCYX) transfers BREXAFEMME NDA to GSK, up to $145.5M - Stock Titan
Why SCYNEXIS Inc. (135A) stock stays resilientEarnings Recap Report & Low Risk High Win Rate Stock Picks - newser.com
Is SCYNEXIS Inc. stock attractive for passive investorsMarket Sentiment Report & Long-Term Safe Investment Plans - newser.com
How to build a dashboard for SCYNEXIS Inc. stockEarnings Overview Report & Risk Controlled Daily Trade Plans - newser.com
Scynexis fungerps among funding recipients - BioWorld MedTech
SCYNEXIS receives $7 million annual grant for antifungal research By Investing.com - Investing.com Nigeria
SCYX Secures Federal Grant for Antifungal Research - GuruFocus
Scynexis Announces Federal Funding of Collaboration Between Hackensack Meridian CDI and Johns Hopkins Researchers to Develop New Therapeutics, Including Novel Fungerps, for Resistant Fungal Infections - The Manila Times
SCYNEXIS Receives $35 Million NIH Grant to Develop Next-Generation Antifungal Therapies - Quiver Quantitative
Scynexis (NASDAQ: SCYX) fungerps program included in $7M NIH CETR grant - Stock Titan
Why SCYNEXIS Inc. (135A) stock benefits from AI revolutionForecast Cut & AI Forecast Swing Trade Picks - newser.com
Live market analysis of SCYNEXIS Inc.July 2025 Recap & Community Verified Trade Signals - newser.com
Will SCYNEXIS Inc. (135A) stock deliver stable dividendsJuly 2025 Closing Moves & Weekly Top Gainers Alerts - newser.com
How geopolitical tensions affect SCYNEXIS Inc. stockEarnings Recap Summary & Consistent Return Investment Signals - newser.com
SCYX | SCYNEXIS Inc. SEC Filings - MarketWatch
How SCYNEXIS Inc. (135A) stock compares with tech leadersPortfolio Gains Report & Weekly High Return Stock Forecasts - Fundação Cultural do Pará
Is SCYNEXIS Inc. stock attractive for ETFsPortfolio Performance Report & Free Technical Confirmation Trade Alerts - Fundação Cultural do Pará
Is SCYNEXIS Inc. stock ready for a breakoutEarnings Summary Report & Capital Efficient Trading Techniques - newser.com
Can SCYNEXIS Inc. stock maintain growth trajectoryLong Setup & Risk Adjusted Swing Trade Ideas - newser.com
Is SCYNEXIS Inc. stock bottoming outForecast Cut & AI Driven Stock Movement Reports - newser.com
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):